Akebia Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 15.10 M | $28.69 M | -0.66% | 7.18% |
VANGUARD GROUP INC | 02/11/2025 | 10.88 M | $20.68 M | 8.08% | 5.17% |
STATE STREET CORP | 02/14/2025 | 6.30 M | $11.98 M | 83.78% | 3.00% |
ALERCE INVESTMENT MANAGEMENT, L.P. | 02/14/2025 | 5.75 M | $10.92 M | 0.00% | 2.73% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 4.80 M | $9.11 M | 0.85% | 2.28% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 3.82 M | $7.26 M | 2.84% | 1.82% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 1.19 M | $2.26 M | -10.00% | 0.57% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 1.03 M | $1.95 M | -1.89% | 0.49% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.00 M | $1.90 M | 106.52% | 0.48% |
FEDERATED HERMES, INC. | 02/13/2025 | 914,003 | $1.74 M | 5.30% | 0.43% |
FMR LLC | 02/13/2025 | 747,006 | $1.42 M | 9.53% | 0.36% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 586,710 | $1.11 M | 3.17% | 0.28% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 586,097 | $1.11 M | 256.14% | 0.28% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 502,127 | $954,042 | 24.07% | 0.24% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 497,547 | $945,340 | 5.93% | 0.24% |
JPMORGAN CHASE & CO | 02/12/2025 | 456,294 | $866,959 | 363.03% | 0.22% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 380,535 | $723,016 | 0.00% | 0.18% |
BARCLAYS PLC | 02/13/2025 | 375,495 | $713,000 | 37.50% | 0.18% |
UBS GROUP AG | 02/14/2025 | 351,091 | $667,073 | 128.48% | 0.17% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 274,452 | $521,459 | 100.00% | 0.13% |
RHUMBLINE ADVISERS | 01/30/2025 | 265,389 | $504,233 | 9.27% | 0.13% |
CITIGROUP INC | 02/12/2025 | 236,786 | $449,894 | 56.39% | 0.11% |
EXOME ASSET MANAGEMENT LLC | 02/14/2025 | 205,956 | $391,316 | 100.00% | 0.10% |
JANE STREET GROUP, LLC | 02/14/2025 | 202,275 | $384,322 | 63.48% | 0.10% |
SAPIENT CAPITAL LLC | 01/29/2025 | 200,000 | $380,000 | 0.00% | 0.10% |
DEUTSCHE BANK AG\ | 02/14/2025 | 181,048 | $343,991 | 64.02% | 0.09% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 179,752 | $341,529 | 100.00% | 0.09% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 169,647 | $322,329 | 737.97% | 0.08% |
FRANKLIN RESOURCES INC | 02/12/2025 | 167,184 | $317,650 | 0.00% | 0.08% |
CREATIVE PLANNING | 02/14/2025 | 166,303 | $315,976 | 43.15% | 0.08% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 156,462 | $297,278 | 10.93% | 0.07% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 143,149 | $271,983 | -23.80% | 0.07% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 137,905 | $263,000 | 8.89% | 0.07% |
MACKENZIE FINANCIAL CORP | 02/20/2025 | 135,392 | $257,245 | 930.38% | 0.06% |
SIMPLEX TRADING, LLC | 02/11/2025 | 128,982 | $245,000 | 100.00% | 0.06% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 126,380 | $239,766 | 10.72% | 0.06% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 125,680 | $238,792 | 100.00% | 0.06% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 122,397 | $232,554 | 23.26% | 0.06% |
INVESCO LTD. | 02/13/2025 | 120,646 | $229,228 | 0.73% | 0.06% |
INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 118,209 | $224,597 | 162.30% | 0.06% |
RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 110,930 | $210,766 | -34.89% | 0.05% |
METLIFE INVESTMENT MANAGEMENT, LLC | 02/13/2025 | 104,030 | $197,657 | 52.84% | 0.05% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 103,422 | $196,502 | -7.02% | 0.05% |
TD WATERHOUSE CANADA INC. | 02/13/2025 | 98,618 | $187,374 | 8.83% | 0.05% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 94,500 | $179,550 | -12.66% | 0.04% |
HIGHTOWER ADVISORS, LLC | 02/07/2025 | 93,350 | $177,365 | 0.00% | 0.04% |
PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 93,151 | $176,987 | 100.00% | 0.04% |
DIAMETRIC CAPITAL, LP | 02/12/2025 | 88,115 | $167,418 | 100.00% | 0.04% |
D. E. SHAW & CO., INC. | 02/14/2025 | 82,661 | $157,056 | -0.36% | 0.04% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 77,640 | $147,516 | 0.00% | 0.04% |
Akebia Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 171 institutional investors and hedge funds held shares of Akebia Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 15.1 M
VANGUARD GROUP INC: 10.88 M
STATE STREET CORP: 6.3 M
Alerce Investment Management, L.P.: 5.75 M
GEODE CAPITAL MANAGEMENT, LLC: 4.8 M
RENAISSANCE TECHNOLOGIES LLC: 3.82 M
32.25% of Akebia Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 82.83 M shares in the last 24 months. This purchase volume represents approximately $154.89 M in transactions.